Randall Michael Giuffre

CIK: 0001759822

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DMAC

DiaMedica Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

DMAC
DiaMedica Therapeutics Inc.
Jun 1, 2026
Award(A)
Stock Option (right to buy)
Direct
40.4K shares-
DMAC
DiaMedica Therapeutics Inc.
Jan 2, 2026
Award(A)
Direct
6.2K shares at avg. $8.42$52K
DMAC
DiaMedica Therapeutics Inc.
Jun 1, 2025
Award(A)
Stock Option (right to buy)
Direct
32.2K shares-
DMAC
DiaMedica Therapeutics Inc.
Feb 13, 2025
Exercise(M)
Direct
12K shares at avg. $2.11$25K
DMAC
DiaMedica Therapeutics Inc.
Feb 13, 2025
Exercise(M)
Direct
5K shares at avg. $3.65$18K
DMAC
DiaMedica Therapeutics Inc.
Jan 2, 2025
Award(A)
Direct
10.9K shares at avg. $5.34$58K

		Type	Shares	Price		Ownership
Jun 1, 2026	DMAC DiaMedica Therapeutics Inc.	Award(A) Stock Option (right to buy)	40,412	-	-	Direct
Jan 2, 2026	DMAC DiaMedica Therapeutics Inc.	Award(A)	6,175	$8.42	$51,994	Direct
Jun 1, 2025	DMAC DiaMedica Therapeutics Inc.	Award(A) Stock Option (right to buy)	32,162	-	-	Direct
Feb 13, 2025	DMAC DiaMedica Therapeutics Inc.	Exercise(M)	12,000	$2.11	$25,320	Direct
Feb 13, 2025	DMAC DiaMedica Therapeutics Inc.	Exercise(M)	5,000	$3.65	$18,250	Direct
Jan 2, 2025	DMAC DiaMedica Therapeutics Inc.	Award(A)	10,861	$5.34	$57,998	Direct

1-6 of 6 transactions

About Giuffre Randall Michael

Giuffre Randall Michael (SEC CIK 0001759822) files insider reports with the SEC as Director of DiaMedica Therapeutics Inc. (DMAC).

Signal8 holds 5 ownership filings by Giuffre Randall Michael, all Form 4s, filed between Jan 3, 2025 and Jun 3, 2026. Those filings report 6 transactions, from Jan 2, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Giuffre Randall Michael's filings is in MINNEAPOLIS, MN.

Recent filings by Giuffre Randall Michael

Jun 1, 2026: Grant or award of DMAC derivative securities (Form 4, code A).
Jan 2, 2026: Grant or award of DMAC shares (Form 4, code A).
Jun 1, 2025: Grant or award of DMAC derivative securities (Form 4, code A).
Feb 13, 2025: Option exercises of DMAC shares (2 lines, Form 4, code M).
Jan 2, 2025: Grant or award of DMAC shares (Form 4, code A).

Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)

Pauls Dietrich John, President & CEO
Kuntz Richard, Director
O'Connor Daniel J., Director
Lewis Tanya, Director
Semba Charles Pauling, Director
Parsons James T., Director

How to read Form 4 transaction codes